Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols

NCT01353664 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT01353664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01353664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
Lead sponsor
Celgene
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2011
Completion date
September 5, 2012
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, lymphoma